Facebook
Twitter
LinkedIn
Forward5th Annual Mayo Clinic Thyroid and Parathyroid Disorders Course 2024
This course offers Live (in-person) and Livestream (virtual) attendance options.
Course Directors: Ejigayehu G. Abate, M.D., Victor Bernet, M.D., John D. Casler, M.D.
November 14 - 16, 2024 - Hyatt Regency Clearwater Beach Resort and Spa - Clearwater, Florida
The 5th Annual Mayo Clinic Thyroid and Parathyroid Disorders Course 2024 is a three-day CME course offering a comprehensive review of diagnostic techniques and medical and surgical management of thyroid and parathyroid disorders. Topics of discussion include the assessment of benign thyroid diseases as well as pre-and postoperative management of thyroid cancer and parathyroid disorders. Discussions include review of cutting-edge imaging modalities and diagnostic methods such as molecular testing for evaluation of thyroid nodules as well as therapeutic options for the management of benign and malignant thyroid and parathyroid conditions. This course consists of a combination of lectures and panel discussions about diagnostic and therapeutic options for management of challenging parathyroid and thyroid cases, as well as roundtable small group discussions with various experienced speakers.
Abstract Session - Deadline September 27, 2024
As part of the 5th Annual Mayo Clinic Thyroid and Parathyroid Disorders Course poster session, the presentation of original research related to the field of diagnostic techniques and medical and surgical management of thyroid and parathyroid disorders will be held at the meeting. Accepted abstract recipients will be notified by email after the deadline. Registration is required for all poster presenters.
Submitted abstracts may include: the assessment of benign thyroid diseases as well as pre-and postoperative management of thyroid cancer and parathyroid disorders; review of cutting-edge imaging modalities and diagnostic methods such as molecular testing for evaluation of thyroid nodules as well as therapeutic options for the management of benign and malignant thyroid and parathyroid conditions. Poster presentations will be peer-reviewed. For further information email FLA CME Abstracts.
Target Audience
The course is designed for endocrinologists, endocrine surgeons, head and neck surgeons, primary care physicians, nurse practitioners, physician assistants, and other providers who care for patients with thyroid and parathyroid disorders.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Review management of common parathyroid disorders, including hyperparathyroidism and hypoparathyroidism.
- Discuss the recent advancements in diagnostic techniques of parathyroid conditions, including imaging modalities.
- Review the latest developments in molecular genetics and targeted therapies for thyroid cancer.
- Discuss modern management of Graves Disease and Thyroid Eye Disease.
- Identify syndromic causes of calcium disorders
- Review surgical management of thyroid nodules and thyroid cancer.
- Review non-surgical management of thyroid nodules and thyroid cancer.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
5th Annual Mayo Clinic Thyroid and Parathyroid Disorders Course 2024 |
Hyatt Regency Clearwater Beach Resort and Spa Clearwater Beach, Florida |
November 14-16, 2024 |
All Presentations Eastern Time |
Thursday, November 14, 2024 | |
7:00 AM | Registration and Breakfast |
7:45 AM | Welcome Introductions and Pre-Test - Parathyroid Ejigayehu G. Abate, M.D., Mayo Clini Florida John D. Casler, M.D., Mayo Clinic Florida Victor J. Bernet, M.D., Mayo Clinic Florida |
8:00 AM | Primary hyperparathyroidism: Getting it right. Shon E. Meek, M.D., Ph.D., Mayo Clinic Florida |
8:25 AM | Primary hyperparathyroidism planning for surgical success Jeffrey R. Janus, M.D., Mayo Clinic Florida |
8:50 AM | Minimally Invasive non-surgical treatments for benign parathyroid lesions: A new frontier (Alcohol ablation and RFA) Ricardo Paz-Fumagalli, M.D., Mayo Clinic Florida |
9:15 AM | Case Discussion: Parathyroid Part 1 Moderator: John D. Casler, M.D., Mayo Clinic Florida Panelists: Robert A. Wermers, M.D., Mayo Clinic Rochester Jeffrey R. Janus, M.D., Mayo Clinic Florida Shon E. Meek, M.D., Ph.D., Mayo Clinic Florida Ricardo Paz-Fumagalli, M.D., Mayo Clinic Florida |
9:45 AM | Q&A Session |
10:00 AM | Coffee Break and Exhibits |
10:25 AM | Diagnosis and Management of Hypoparathyroidism in 2024: Palopegteriparatide (Transcon PTH) and upcoming treatments Michael Mannstadt, M.D., Harvard Medical School |
10:50 AM | Hypoparathyroidism’s: Strategies for Clinicians on Monitoring, managing complications, and Enhancing Patient Collaboration for optimal Care Michael Mannstadt, M.D., Harvard Medical School |
11:15 AM | Recognizing syndromic causes of calcium disorders Peter J. Tebben, M.D., Mayo Clinic Rochester |
11:40 AM | Case Discussion: Parathyroid Part 2 Moderator: Ejigayehu G. Abate, M.D., Mayo Clini Florida Panelists: Michael Mannstadt, M.D., Harvard Medical School Peter J. Tebben, M.D., Mayo Clinic Rochester Jeffrey R. Janus, M.D., Mayo Clinic Florida Robert A. Wermers, M.D., Mayo Clinic Rochester |
12:10 PM | Q&A Session |
12:25 PM | Lunch |
1:25 PM | Collaborative Strategies: How Endocrinologists and Parathyroid Surgeons Work Together to Tackle Persistent Parathyroid Disorders Robert A. Wermers, M.D., Mayo Clinic Rochester |
1:50 PM | Normocalcemic, Secondary, Tertiary hyperparathyroidism and posttransplant hyperparathyroidism Robert A. Wermers, M.D., Mayo Clinic Rochester |
2:15 PM | Nephrolithiasis: A nephrologist perspective Ivan E. Porter II, M.D., May Clinic Florida |
2:40 PM | Case Discussion: Renal related Parathyroid Cases Moderator: Robert A. Wermers, M.D., Mayo Clinic Rochester Panelists: Shon E. Meek, M.D., Ph.D., Mayo Clinic Florida Peter J. Tebben, M.D., Mayo Clinic Rochester Ivan E. Porter II, M.D., May Clinic Florida Ejigayehu G. Abate, M.D., Mayo Clini Florida |
3:10 PM | Q&A Session |
3:25 PM | Coffee Break and Exhibits |
3:50 PM | Phosphorus disorders: Pearls for clinicians and surgeons Peter J. Tebben, M.D., Mayo Clinic Rochester |
4:15 PM | Hypercalcemia beyond PTH Shon E. Meek, M.D., Ph.D., Mayo Clinic Florida |
4:40 PM | Case Discussions: Parathyroid disorders and beyond Moderator: Ejigayehu G. Abate, M.D., Mayo Clini Florida Panelists: Shon E. Meek, M.D., Ph.D., Mayo Clinic Florida Peter J. Tebben, M.D., Mayo Clinic Rochester |
5:10 PM | Q&A Session |
5:25 PM | Post-Test Parathyroid |
5:35 PM | Welcome Reception, Poster Session and Networking |
| ADJOURN – End of Day 1 |
Friday, November 15, 2024 | |
7:00 AM | Registration and Breakfast |
7:50 AM | Welcome Introductions and Pre-Test - Thyroid Victor Bernet, M.D., Mayo Clinic Florida John D. Casler, M.D., Mayo Clinic Florida |
8:00 AM | Hyperthyroidism & Thyroid Eye Disease- What’s New? Marius N. Stan, M.D., Mayo Clinic Rochester |
8:25 AM | The Treatment of Hypothyroidism: Myths and Facts Juan P. Brito M.B.B.S, Mayo Clinic Rochester |
8:50 AM | Thyroid Function Anomalies: Unraveling the Complexities Victor J. Bernet, M.D., Mayo Clinic Florida |
9:15 AM | Case Discussions: Thyroid Function Issues Moderator: Ana-Maria Chindris, MD, Mayo Clinic Florida Panelists: Marius N. Stan, M.D., Mayo Clinic Rochester Juan P. Brito M.B.B.S, Mayo Clinic Rochester Victor J. Bernet, M.D., Mayo Clinic Florida |
9:45 AM | Q&A Session |
10:00 AM | Coffee Break and Exhibits |
10:25 AM | Advancements in thyroid nodule management: New ATA guidelines Victor J. Bernet, M.D., Mayo Clinic Florida |
10:50 AM | Surgical strategies for optimizing management of Benign Thyroid Disorders Samip Patel, M.D., Mayo Clinic Florida |
11:15 AM | Beyond the Knife: Innovative Approaches to Thyroid Nodules and Cancer Management Ricardo Paz- Fumagalli, M.D., Mayo Clinic Florida |
11:40 AM | Case Discussion: Benign Thyroid Disorders Moderator: Marius N. Stan, M.D., Mayo Clinic Rochester Panelists: Victor J. Bernet, M.D., Mayo Clinic Florida Samip Patel, M.D., Mayo Clinic Florida Ricardo Paz- Fumagalli, M.D., Mayo Clinic Florida |
12:10 PM | Q&A Session |
12:25 PM | Practice Optimization: The integration of advanced practice providers into thyroid and parathyroid Practice Moderators: Victor J. Bernet, M.D., Mayo Clinic Florida Panelists: Allyson W. McNally, APRN, D.N.P., Mayo Clinic Florida Catherine G. Coyle, APRN, D.N.P., Mayo Clinic Florida Ejigayehu G. Abate, M.D., Mayo Clini Florida John D. Casler, M.D., Mayo Clinic Florida |
12:55 PM | ADJOURN – End of Day 2 |
Saturday, November 16, 2024 | |
7:00 AM | Registration and Breakfast |
7:50 AM | Welcome Introductions Victor Bernet, M.D., Mayo Clinic Florida John D. Casler, M.D., Mayo Clinic Florida |
8:00 AM | Thyroid Cancer: The Newest Trends in Management; updated ATA guidelines Whitney S. Goldner, M.D., University of Colorado |
8:25 AM | Monitoring Thyroid Cancer: The Balance of When to Watch and When to Act. Kaniksha Desai, M.D., Stanford University |
8:50 AM | Too much or not enough? Striking the balance on the extent of thyroid surgery Jeffrey R. Janus, M.D., Mayo Clinic Florida |
9:15 AM | Case Discussion: Thyroid Cancer Cases Part I Moderator: Sarika N. Rao, D.O., Mayo Clinic Florida Panelists: Whitney S. Goldner, M.D., University of Colorado Kaniksha Desai, M.D., Stanford University Jeffrey R. Janus, M.D., Mayo Clinic Florida |
9:45 AM | Q&A Session |
10:00 AM | Coffee Break and Exhibits |
10:25 AM | Innovative Care Strategies for Patients with Advanced Differentiated Thyroid Cancer Julie E. Hallanger-Johnson, M.D., Mayo Clinic Rochester |
10:50 AM | Oncocytic (Hürthle cell) Thyroid Cancer: New paradigm for Management Ana-Maria Chindris, M.D., Mayo Clinic Florida |
11:15 AM | The Nuclear Medicine toolbox: options for diagnosis and management of thyroid cancer Manoj K. Jain, M.D., Mayo Clinic Florida |
11:40 AM | Navigating the complications from Systemic Therapy Sarika N. Rao, D.O., Mayo Clinic Florida |
12:05 PM | Case Discussion: Thyroid Cancer Cases Part 2 Moderator: Victor J. Bernet, MD, Mayo Clinic Florida Panelists: Julie E. Hallanger-Johnson, M.D., Mayo Clinic Rochester Ana-Maria Chindris, M.D., Mayo Clinic Florida Whitney S. Goldner, M.D., University of Colorado Jeffrey R. Janus, M.D., Mayo Clinic Florida |
12:35 PM | Q&A Session |
12:50 PM | Post-Test Thyroid |
1:00 PM | Closing Remarks |
1:10 PM | ADJOURN – End of Day 3 |
Plan your beachfront escape at Hyatt Regency Clearwater Beach Resort and Spa. A block of rooms has been reserved for attendees at a special rate of $299 per night plus applicable taxes and fees. Reservations must be made before the room block sells out or before the expiration date of October 18, 2024, whichever comes first. The discounted rate is available three days prior and three days after the course dates based upon availability of group rooms at the time of the request. Discounted Resort Fee of $25 per night will apply.
Please follow the LINK to make your reservation.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Course Directors:
Ejigayehu G. Abate, M.D.
Victor Bernet, M.D.
John D. Casler, M.D.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 17.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AOA
The American Osteopathic Association designates this program for a maximum of 17.25 AOA Category 2-A credits
AAFP
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
IPCE
This activity was planned by and for the healthcare team, and learners will receive 17.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
| Day | Credit |
|---|---|
| Thursday | 8.00 |
| Friday | 4.50 |
| Saturday | 4.75 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 17.25 AMA PRA Category 1 Credit™
- 17.25 ANCC
- 17.25 AOA Category 2-A
- 17.25 Attendance
- 17.25 IPCE
The 5th Annual Mayo Clinic Thyroid and Parathyroid Disorders Course 2024 course is pleased to offer the opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibiting at this course, please click on the below link.
Review the Exhibit Prospectus.
Complete the Exhibitor Agreement Form to apply for an exhibit table.
If you have any additional questions please contact: Ashley Cotto
Please update your profile to let us know if you have dietary restrictions or access requirements.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.